Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 5976519, 8 pages
https://doi.org/10.1155/2018/5976519
Research Article

Treatment of Hyperoxia-Induced Lung Injury with Lung Mesenchymal Stem Cells in Mice

Yabo Mei,1,2,3 Chong Chen,4 Hui Dong,5 Wanqiao Zhang,1,2,3 Yan Wang,1,2,3 Ming Chi,1,2,3 and Zhichun Feng1,2,3

1Department of Pediatrics, Affiliated BaYi Children’s Hospital, PLA Army General Hospital, Beijing, China
2The National Engineering Laboratory for Birth Defects Prevention and Control of Key Technology, Beijing, China
3Beijing Key Laboratory of Pediatric Organ Failure, Beijing, China
4Department of Pediatrics, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing, China
5Neonatal Intensive Care Unit of Jining No. 1 People’s Hospital, Jining, Shangdong Province, China

Correspondence should be addressed to Yabo Mei; moc.361@3002bym

Received 21 March 2018; Revised 3 July 2018; Accepted 31 July 2018; Published 26 September 2018

Academic Editor: Ce Yang

Copyright © 2018 Yabo Mei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Van Marter, “Epidemiology of bronchopulmonary dysplasia,” Seminars in Fetal & Neonatal Medicine, vol. 14, no. 6, pp. 358–366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. W. H. Northway Jr., R. C. Rosan, and D. Y. Porter, “Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia,” The New England Journal of Medicine, vol. 276, no. 7, pp. 357–368, 1967. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. Simones, D. J. Beisang, A. Panoskaltsis-Mortari, and K. D. Roberts, “Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review,” Pediatric Research, vol. 83, no. 1-2, pp. 308–317, 2018. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Pierro, L. Ionescu, T. Montemurro et al., “Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia,” Thorax, vol. 68, no. 5, pp. 475–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Ionescu, R. N. Byrne, T. van Haaften et al., “Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 303, no. 11, pp. L967–L977, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Augustine, M. T. Avey, B. Harrison et al., “Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies,” Stem Cells Translational Medicine, vol. 6, no. 12, pp. 2079–2093, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. P. Collins and B. Thébaud, “Lung mesenchymal stromal cells in development and disease: to serve and protect?” Antioxidants & Redox Signaling, vol. 21, no. 13, pp. 1849–1862, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. P. Ingenito, L. Tsai, S. Murthy, S. Tyagi, M. Mazan, and A. Hoffman, “Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema,” Cell Transplantation, vol. 21, no. 1, pp. 175–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Hoffman, J. A. Paxson, M. R. Mazan et al., “Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung,” Stem Cells and Development, vol. 20, no. 10, pp. 1779–1792, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Jun, C. Garat, J. West et al., “The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation,” Stem Cells, vol. 29, no. 4, pp. 725–735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Sinclair, S. T. Yerkovich, and D. C. Chambers, “Mesenchymal stem cells and the lung,” Respirology, vol. 18, no. 3, pp. 397–411, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. P. Popova, P. D. Bozyk, J. Kelley Bentley et al., “Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia,” Pediatrics, vol. 127, no. 2, article peds.2009-3445d, 2011. View at Publisher · View at Google Scholar
  13. G. Vento, E. Capoluongo, P. G. Matassa et al., “Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia,” Intensive Care Medicine, vol. 32, no. 5, pp. 723–730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kotecha, A. Wangoo, M. Silverman, and R. J. Shaw, “Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity,” The Journal of Pediatrics, vol. 128, no. 4, pp. 464–469, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. A. N. Husain, N. H. Siddiqui, and J. T. Stocker, “Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia,” Human Pathology, vol. 29, no. 7, pp. 710–717, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Toti, G. Buonocore, P. Tanganelli et al., “Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study,” Pediatric Pulmonology, vol. 24, no. 1, pp. 22–28, 1997. View at Publisher · View at Google Scholar
  17. X. Gong, Z. Sun, D. Cui et al., “Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells,” Cell Biology International, vol. 38, no. 4, pp. 405–411, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Zhang, W. Peng, S. Zhang et al., “MicroRNA expression profile in hyperoxia-exposed newborn mice during the development of bronchopulmonary dysplasia,” Respiratory Care, vol. 56, no. 7, pp. 1009–1015, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Gallini, R. Arena, G. Stella, S. Frezza, and L. Maggio, “Neurodevelopmental outcomes of premature infants with bronchopulmonary dysplasia,” Acta Bio-Medica, vol. 85, no. 1, pp. 30–34, 2014. View at Google Scholar
  20. V. Compernolle, K. Brusselmans, T. Acker et al., “Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice,” Nature Medicine, vol. 8, no. 7, pp. 702–710, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Bhandari, R. Choo-Wing, C. G. Lee et al., “Developmental regulation of NO-mediated VEGF-induced effects in the lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 39, no. 4, pp. 420–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Abadie, F. Bregeon, L. Papazian et al., “Decreased VEGF concentration in lung tissue and vascular injury during ARDS,” European Respiratory Journal, vol. 25, no. 1, pp. 139–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. G. Peters, C. De Vries, and L. T. Williams, “Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 19, pp. 8915–8919, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Pierro, B. Thébaud, and R. Soll, “Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants,” Cochrane Database of Systematic Reviews, vol. 11, article CD011932, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Möbius and M. Rüdiger, “Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia,” Molecular and Cellular Pediatrics, vol. 3, no. 1, p. 18, 2016. View at Publisher · View at Google Scholar
  26. E. El Agha and S. Bellusci, “Walking along the fibroblast growth factor 10 route: a key pathway to understand the control and regulation of epithelial and mesenchymal cell-lineage formation during lung development and repair after injury,” Scientifica, vol. 2014, Article ID 538379, 20 pages, 2014. View at Publisher · View at Google Scholar
  27. M. A. Möbius and B. Thébaud, “Bronchopulmonary dysplasia: where have all the stem cells gone?: Origin and (potential) function of resident lung stem cells,” Chest, vol. 152, no. 5, pp. 1043–1052, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. C. E. Barkauskas, M. J. Cronce, C. R. Rackley et al., “Type 2 alveolar cells are stem cells in adult lung,” Journal of Clinical Investigation, vol. 123, no. 7, pp. 3025–3036, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. van Haaften, R. Byrne, S. Bonnet et al., “Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 11, pp. 1131–1142, 2009. View at Publisher · View at Google Scholar · View at Scopus